Trials / Sponsors / SL VAXiGEN
SL VAXiGEN
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCR Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 1 | 2022-10-17 |
| Unknown | Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recip Cytomegalovirus Infections, Preventation of Cytomegalovirus Reactivation, BK Virus Infection | Phase 1 | 2018-04-27 |